Recce Pharmaceuticals Secures Approval for Diabetic Food Infection Clinical Trial in Indonesia; Shares Rise 5%

MT NewswiresDec 8 22:17 ET

Recce Pharmaceuticals Advances Phase 3 Trial in Indonesia

TipRanksDec 8 18:17 ET

Recce Pharmaceuticals Ready for Phase 3 Clinical Trial of R327G in Diabetic Foot Infections in Indonesia | ASX:RCE, OTC:RECEF

Proactive InvestorsDec 8 18:00 ET

Investors in Recce Pharmaceuticals (ASX:RCE) Have Seen Notable Returns of 68% Over the Past Five Years

Yahoo FinanceDec 1 17:52 ET

Recce Pharmaceuticals Secures Australian Patent for Anti-infectives; Covered in All Major Markets

Investing.com Nov 25 18:10 ET

Complete Patent Protection for 2 Recce Anti-infective Treatments

The Market HeraldNov 25 18:07 ET